Startdatum
Einddatum
Auteur
SecretariaatNVKF

Scientific Project Day

We kindly invite you to participate in the first RKF meeting of 2025.

 

 

Location 

Leiden University Medical Center, Collegezaal 5, Route 558.

Practical information

LUMC is right next to Leiden Centraal train station with frequent connections of local and intercity trains, see ns.nl. Parking is available for visitors: set your navigation to “LUMC parkeergarage”.

From the main entrance to the hospital follow the signs for Route 558. Collegezaal 5 is on the first floor. 

Lunch will be provided. Any special dietary requirements can be indicated during registration.

Registration

Please use this link to register.

Scientific program

TimeTitleNameAffiliation
10:00Opening remarks  
Innovations in brachytherapy
10:05Target auto-segmentation for MRI-guided cervix brachytherapyRita Simoes AvL
10:20AI-Driven Needle Reconstruction for MRI-Guided Brachytherapy: Addressing Challenges and Practical ConsiderationsVangelis Kostoulas LUMC
10:35Temporal change in source strength measument of Ir-192 brachytherapy sources:  A Multi-center analysis of dosimetric accuracy and implications for clinical practice (GEC ESTRO BRAPHYQS group)Ruud van LeeuwenRadboud UMC
10:50Developing optimised 3D printed patient-tailored brachytherapy applicatorRobin StraathofErasmus MC
11:05Coffee break
Modeling of toxicity in protons and photons
11:20NTCP modeling for gastrointestinal toxicities after postoperative (chemo)radiotherapy in cervical cancerAnouk CorbeauLUMC
11:35Imputation method comparison on longitudinal reported toxicity scoresLuuk van der HoekUMCG
11:50Deep learning NTCP models for head and neck cancer toxicitiesSuzanne de VetteUMCG
12:05Improving deep learning NTCP models through multi-label learningDaniel MacRaeUMCG
12:20Lunch break
Treatment planning and validation; QA in trials and clinical practice
13:15Validation of automated IMPT- and joint proton transmission beam-IMPT planning for nasopharyngeal cancer patientsMerle HuiskensLUMC
13:30Primary endpoint analysis of the phase II DESTINATION-MRL trial for patients with intermediate-risk prostate cancerThijs Dassen AvL
13:45Automatic prospective QA of delineation and planning for the hypoFLAME 3.0 trialJoost Surewaard AvL
14:00Process risk analysis for linac and TPS acceptance and commissioning Leo van Battum AUMC
14:15A proposition to revise the machine and patient-specific QA to be applicable in the next decadeThijs PerikAvL
14:30Quality assurance for dose accumulation in IGRTLando BosmaUMCU
14:45Enhancing Patient Comfort in Palliative Radiotherapy with a Newly Developed Mattress: A Prospective Clinical StudyNienke Hoffmans – HoltzerErasmus MC
15:00Tea break
Motion and adaptation; Imaging
15:15Evaluating The Interplay Effect in Lung and Esophageal Cancer Proton Therapy: Is Volumetric Repainting Essential for Free-Breathing Treatments?”Giorgio Cartechini Maastro
15:30Biophysically-informed motion estimation in image-guided radiotherapyTom DraperUMCU
15:45Accelerating the MRL ATS workflowGijs BolUMCU
16:00Assessing a novel photon counting computed tomography for quantitative imaging accuracy in radiotherapyDidier Lustermans Maastro
16:15The potential of photon-counting computed tomography for improved stopping power prediction in proton therapySophie HuijskensErasmus MC
16:30Closing remarks & drinks